Kaiquan Zhu1,
Renyu Lin1,
Aidan Xiaguang2
For correspondence:- Aidan Xiaguang Email: AidanXiadyu@163.com Tel:+8657788306139
Accepted: 30 October 2019 Published: 30 November 2019
Citation: Zhu K, Lin R, Xiaguang A. MiR-646 targets PDK1 to recede aerobic glycolysis and cell proliferation in nasopharyngeal carcinoma. Trop J Pharm Res 2019; 18(11):2299-2304 doi: 10.4314/tjpr.v18i11.10
© 2019 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..
Archives
News Updates